Gryska David W
CIK 0001202335
Director
Filings
20
Latest Jun 2, 2026
Issuers covered
4
Showing
20 of 20
Page 1
Track record
2 of 13 open-market trades scored (15% price coverage) - 11 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +2.8% | +2.8% | +8.2% | -2.5% |
| 90 days | 2 | 50% | +3.8% | +3.8% | +17.8% | -10.3% |
| 180 days | 2 | 100% | +22.8% | +22.8% | +37.5% | +8.2% |
| 365 days | 2 | 100% | +68.7% | +68.7% | +73.7% | +63.6% |
Issuers
Companies where Gryska David W has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SGEN | Seagen Inc. | 8 | Dec 15, 2023 |
| FBRX | Forte Biosciences, Inc. | 6 | Jun 2, 2026 |
| MNMD | Mind Medicine (Mindmed) Inc. | 5 | Jun 16, 2025 |
| AERI | Aerie Pharmaceuticals Inc | 1 | Jun 13, 2022 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|